510(k) K031563

BINDAZYME CLQ CIC EIA KIT by The Binding Site, Ltd. — Product Code DAK

K031563 is an FDA 510(k) premarket notification submitted by The Binding Site, Ltd. for the device "BINDAZYME CLQ CIC EIA KIT". The FDA issued a decision of Substantially Equivalent on September 10, 2003. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. The Binding Site, Ltd. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 10, 2003
Date Received
May 19, 2003
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Complement C1q, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5240
Review Panel
IM
Submission Type